Barclays’s Crinetics Pharmaceuticals CRNX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $3.88M | Sell |
106,734
-78,943
| -43% | -$3.53M | ﹤0.01% | 1975 |
|
|
2025
Q4 | $8.64M | Buy |
185,677
+2,441
| +1% | +$109K | ﹤0.01% | 1786 |
|
|
2025
Q3 | $7.63M | Sell |
183,236
-108,811
| -37% | -$3.48M | ﹤0.01% | 1872 |
|
|
2025
Q2 | $8.4M | Buy |
292,047
+126,136
| +76% | +$3.9M | ﹤0.01% | 1695 |
|
|
2025
Q1 | $5.56M | Sell |
165,911
-16,030
| -9% | -$599K | ﹤0.01% | 1825 |
|
|
2024
Q4 | $9.3M | Sell |
181,941
-25,771
| -12% | -$1.44M | ﹤0.01% | 1624 |
|
|
2024
Q3 | $10.6M | Buy |
207,712
+89,358
| +76% | +$4.61M | ﹤0.01% | 1447 |
|
|
2024
Q2 | $5.3M | Buy |
118,354
+43,459
| +58% | +$2.01M | ﹤0.01% | 1494 |
|
|
2024
Q1 | $3.51M | Sell |
74,895
-116,089
| -61% | -$4.54M | ﹤0.01% | 2095 |
|
|
2023
Q4 | $6.8M | Buy |
190,984
+77,702
| +69% | +$2.38M | ﹤0.01% | 1842 |
|
|
2023
Q3 | $3.37M | Buy |
113,282
+21,189
| +23% | +$437K | ﹤0.01% | 1571 |
|
|
2023
Q2 | $1.66M | Sell |
92,093
-17,180
| -16% | -$343K | ﹤0.01% | 2004 |
|
|
2023
Q1 | $1.75M | Buy |
109,273
+40,430
| +59% | +$748K | ﹤0.01% | 2289 |
|
|
2022
Q4 | $1.26M | Buy |
68,843
+18,238
| +36% | +$321K | ﹤0.01% | 2622 |
|
|
2022
Q3 | $994K | Buy |
50,605
+46,563
| +1,152% | +$950K | ﹤0.01% | 2238 |
|
|
2022
Q2 | $75K | Sell |
4,042
-5,444
| -57% | -$109K | ﹤0.01% | 3888 |
|
|
2022
Q1 | $208K | Sell |
9,486
-48,301
| -84% | -$978K | ﹤0.01% | 3411 |
|
|
2021
Q4 | $1.64M | Buy |
57,787
+40,652
| +237% | +$1M | ﹤0.01% | 2501 |
|
|
2021
Q3 | $361K | Buy |
17,135
+2,074
| +14% | +$43.4K | ﹤0.01% | 3342 |
|
|
2021
Q2 | $283K | Sell |
15,061
-9,521
| -39% | -$167K | ﹤0.01% | 3390 |
|
|
2021
Q1 | $375K | Buy |
24,582
+13,674
| +125% | +$212K | ﹤0.01% | 3359 |
|
|
2020
Q4 | $153K | Sell |
10,908
-3,333
| -23% | -$46.4K | ﹤0.01% | 3919 |
|
|
2020
Q3 | $223K | Sell |
14,241
-2,547
| -15% | -$38.9K | ﹤0.01% | 3777 |
|
|
2020
Q2 | $295K | Buy |
16,788
+13,128
| +359% | +$224K | ﹤0.01% | 3766 |
|
|
2020
Q1 | $54K | Sell |
3,660
-7,538
| -67% | -$154K | ﹤0.01% | 5183 |
|
|
2019
Q4 | $281K | Buy |
11,198
+5,215
| +87% | +$99.3K | ﹤0.01% | 4773 |
|
|
2019
Q3 | $90K | Sell |
5,983
-2,650
| -31% | -$51.5K | ﹤0.01% | 5551 |
|
|
2019
Q2 | $216K | Buy |
8,633
+3,311
| +62% | +$82K | ﹤0.01% | 5033 |
|
|
2019
Q1 | $121K | Buy |
+5,322
| New | +$131K | ﹤0.01% | 5209 |
|
|
2018
Q4 | – | Sell |
-2,608
| Closed | -$75K | – | 6987 |
|
|
2018
Q3 | $75K | Buy |
+2,608
| New | +$77.4K | ﹤0.01% | 5797 |
|
Other funds holding CRNX
FCM
DCM
VCM
VPM
EC